Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Colorcon
Express Scripts
Fish and Richardson
Mallinckrodt
McKesson

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 8,006,698

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,006,698
Title:Aerosol therapy device
Abstract: The invention regards a therapeutic aerosol device in which a main aerosol flow, which is generated with the help of a compressed gas and is supplied to one of the nostrils of a user, is superimposed by pressure fluctuations. The superimposition of the pressure fluctuations occurs directly at one of the two nostrils of the user. A flow resistance is provided in the other nostril.
Inventor(s): Boehm; Andreas (Reichling, DE), Luber; Martin (Munich, DE), Rosenbeiger; Sven (Starnberg, DE)
Assignee: PARI GmbH Spezialisten fuer effektive Inhalation (Starnberg, DE)
Application Number:11/650,817
Patent Claims:see list of patent claims

Details for Patent 8,006,698

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20   Try a Free Trial PARI GmbH Spezialisten fuer effektive Inhalation (Starnberg, DE) 2026-01-09 RX search
Amgen NEUPOGEN filgrastim VIAL 103353 002 1991-02-20   Try a Free Trial PARI GmbH Spezialisten fuer effektive Inhalation (Starnberg, DE) 2026-01-09 RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 003 1991-02-20   Try a Free Trial PARI GmbH Spezialisten fuer effektive Inhalation (Starnberg, DE) 2026-01-09 RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20   Try a Free Trial PARI GmbH Spezialisten fuer effektive Inhalation (Starnberg, DE) 2026-01-09 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald
Covington
Colorcon
Fuji
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.